Pyrazolopyridine derivatives as pharmaceutical agents
US7365066B2 · kind B2 · utility
4Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2003 |
| Grant date | Apr 29, 2008 |
| Priority date | — |
| Expiry date | Dec 10, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel pyrazolopyridine derivative compounds are disclosed and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors useful in the treatment of cancer and other disease states influenced by TGF beta.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.